Related Experiment Video
Updated: Aug 10, 2026

12:34
Collection, Isolation, and Flow Cytometric Analysis of Human Endocervical Samples
Published on: July 6, 2014
Endocervical glandular lesions: controversial aspects and ancillary techniques
1Department of Pathology, Royal Group of Hospitals Trust, Belfast, UK. glenn.mccluggage@bll.n-i.nhs.uk
Journal of Clinical Pathology
|March 1, 2003
Summary
This review addresses the increasing incidence of malignant and premalignant endocervical glandular lesions. It clarifies diagnostic challenges, terminology differences, and histological distinctions for accurate classification.
Area of Science:
- Gynecologic Pathology
- Cervical Cancer Diagnosis
- Histopathology
Background:
- Rising incidence of malignant and premalignant endocervical glandular lesions.
- Diagnostic challenges and controversies in categorizing these lesions.
- Discrepancies in terminology between UK and World Health Organization (WHO) classifications.
Purpose of the Study:
- To review controversial aspects of endocervical glandular lesion categorization and diagnosis.
- To describe morphology and histological subtypes of premalignant lesions.
- To discuss the distinction between benign mimics and malignant/premalignant lesions.
Main Methods:
- Review of current literature on endocervical glandular lesions.
- Discussion of histological features and diagnostic criteria.
- Evaluation of immunohistochemical markers for differential diagnosis.
Main Results:
- Detailed description of premalignant endocervical glandular lesion morphology and subtypes.
- Analysis of diagnostic difficulties in early invasive adenocarcinoma and invasion measurement.
- Identification of benign lesions mimicking malignant/premalignant conditions.
- Review of immunohistochemical antibodies for distinguishing endometrial vs. endocervical adenocarcinoma, adenoma malignum, and mesonephric lesions.
Conclusions:
- Accurate classification of endocervical glandular lesions requires understanding terminology differences and histological nuances.
- Immunohistochemistry plays a crucial role in differentiating benign mimics and specific subtypes of adenocarcinoma.
- Improved diagnostic strategies are needed to address the rising incidence of these lesions.

